论文部分内容阅读
目的:分析研究盐酸氨溴索加盐酸丙卡特罗治疗在小儿肺炎的临床效果。方法:选取我院在2014年6月至2015年1月间收治的110例小儿肺炎患者,每组55例。对照组的患者被给予常规治疗包括口服维生素C、常规抗感染和降温等。对照组为常规治疗,观察组在常规治疗基础上采用盐酸氨溴索加盐酸丙卡特罗治疗,比较两组患儿的临床疗效与症状消失时间。结果:观察组总有效率为94.54%,对照组总有效率为81.81%,两组患者的治疗有效率存在明显差异性,服用盐酸氨溴索加盐酸丙卡特罗的患者治疗效果好于对照组。结论:盐酸氨溴索加盐酸丙卡特罗在小儿肺炎治疗中能够取得明显疗效,可以促进患儿疾病症状的改善,取得显著的效果,更具安全性,起效时间快,值得临床推广应用。
Objective: To analyze the clinical effect of ambroxol hydrochloride and procaterol hydrochloride in children with pneumonia. Methods: A total of 110 pediatric pneumonia patients were enrolled in our hospital from June 2014 to January 2015, with 55 cases in each group. Patients in the control group were given routine treatment including oral vitamin C, conventional anti-infection and cooling. The control group was treated routinely, and the observation group was treated with ambroxol hydrochloride and procaterol hydrochloride on the basis of conventional treatment. The clinical efficacy and symptom disappearance time of the two groups were compared. Results: The total effective rate was 94.54% in the observation group and 81.81% in the control group. There was a significant difference in the treatment efficiency between the two groups. The treatment effect of ambroxol hydrochloride and procaterol hydrochloride was better than that of the control group . Conclusions: Ambroxol hydrochloride and procaterol hydrochloride can achieve significant curative effect in the treatment of pediatric pneumonia, which can promote the improvement of the disease symptoms in children, and achieve remarkable results, more safety, faster onset of action and worthy of clinical application.